Enregistrement - Lobbyistes-conseils

Objets

• Éducation
• Emploi et formation
• Environnement
• Immigration
• Impôts et finances
• Industrie
• Institutions financières
• Justice et application des lois
• Questions touchant les consommateurs
• Radiodiffusion
• Santé
• Sciences et technologies
• Sports
• Transports

Détails sur l'objet

Politique ou Programme

• ABORIGINAL HEALTH ISSUES: Improvement to the health and health care services provide to aboriginal people in Canada
• CANADIAN PHARMACEUTICAL STRATEGY: A national strategy to ensure all Canadian have access to safe, effective and affordable prescription drugs regardless of employment status or geography
• CHILD HEALTH: Increased investments and improved regulation to protect and enhance the health of children
• CROSS BORDER BULK PURCHASING OF DRUGS: Government prohibition against the bulk sale of prescription drugs from Canada to other countries
• EMERGENCY PREPAREDNESS: The adoption of a health emergencies Act to protect the health of Canadians in time of a national health emergency
• ENVIRONMENT AND HEALTH ISSUES: Improvement in federal legislation to improve air, water and soil quality
• FEDERAL HEALTH PROGRAMS AND FEDERAL FORMS: Improved compensation for the completion of federal health forms by physicians
• HEALTH INFORMATION TECHNOLOGIES (ELECTRONIC MEDICAL AND HEALTH RECORDS): Investment and needed regulations to facilitate the development of EHRs and EMRs in Canada
• HEALTH PROMOTION AND DISEASE PREVENTION: Increased investment and improved regulations to protect and enhance the health of Canadians
• HEALTHY LIVING INITIATIVES: Encouraging governments to fund programs to promote healthy living
• HUMAN RIGHTS FOREIGN CARE WORKERS: Canada to speak out internationally on the right of physicians to provide medical care for their populations
• IMPAIRED DRIVING: Increased measure to both mitigate impaired driving in Canada
• INTERNET PRESCRIBING: Prohibitions against the prescribing of pharmaceuticals over the internet
• LONG-TERM CARE: Increase investments and changes to the Tax Act to enhance long-term care
• MANDATORY REPORTING OF ADVERSE DRUG EFFECTS: Ensuring that changes to report of adverse drug reaction is in the interest of patients and providers
• MEDICAL EDUCATION: Increase funding for medical education
• MENTAL HEALTH AND NATIONAL STRATEGY: Increased investment by the federal government to improve programs and services for the mentally ill
• NATIONAL DEFENSE MEDICAL PERSONNEL: Increasing funding to ensure an adequate supply of national defence medical personnel
• NATIONAL HEALTH GOALS: The establishment of national health goals for the Canadian population
• NATIONAL TOBACCO CONTROL PROGRAMS: Increased restriction on the sale and advertising of tobacco products in Canada
• ORGAN AND TISSUE DONATION: Improvements to existing legislation that governs organ and tissue donation in Canada
• PAN-CANADIAN HEALTH HUMAN RESOURCE STRATEGY (INTERNATIONAL MEDICAL GRADUATES): Federal strategies and investments into addressing Canada’s health human resource shortages
• PATIENT SAFETY: National Standards for patient care
• PRIMARY HEALTH CARE RENEWAL: Ensuring that reforms to primary care delivery reflect the interest of patients and providers
• RETIREMENT INCOME ISSUES: Ensuring that Canadian physicians are able to save adequately for retirement
• SUSTAINABILITY OF HEALTH CARE (FINANCING AND ACCESSIBILITY): Increases in health transfer funding and accountability by the federal government
• TELEHEALTH: Increased investment in providing telehealth to rural and remote communities
• TUITION LEVELS AND STUDENT DEBT LOADS (FEDERAL STUDENT LOANS): Increase federal aid for medical students and residents
• WAIT TIMES AND BENCHMARKS: The establishment of medically based wait time benchmarks in areas of specialty and primary care

Proposition législative, Projet de loi ou résolution

• EXCISE TAX ACT: GST AND PHYSICIAN SERVICES: Changes to the application of the GST (zero-rate) on Physician practices
• INCOME TAX ACT: REGISTERED RETIREMENT SAVING PLAN (RRSP) LIMITS: Increasing the contributions limits to RRSPs
• PRE-BUDGET CONSULTATIONS: Federal investments or taxation changes to improve the health care system and the health of Canadians

Règlement

• CANADA PENSION PLAN: Improvements in both administration and compensation of the programs
• MEDICINAL MARIJUANA REGULATIONS: Improving regulations as they relate to the prescribing of medical marijuana
• PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA): PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information

Techniques de communication

• Communication écrite
• Communication orale
• Appel au grand public

Institutions gouvernementales

• Affaires autochtones et Développement du Nord Canada
• Agence canadienne de développement international (ACDI)
• Agence de la santé publique du Canada (ASPC)
• Anciens Combattants Canada (ACC)
• Bureau du Conseil privé (BCP)
• Canada Health Infoway
• Canadian Health Council
• Canadian Institute for Health Information
• Canadian Patient Safety Institute
• Commissaire à l'information et à la protection de la vie privée (CIPVP)
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Conseil de la radiodiffusion et des télécommunications canadiennes (CRTC)
• Députés de la Chambre des communes
• Développement des ressources humaines Canada (DRHC)
• Environnement Canada
• Finances Canada (FIN)
• Industrie Canada
• Instituts de recherche en santé du Canada (IRSC)
• Intergovernmental Affairs
• Justice Canada (JC)
• Patrimoine canadien (PCH)
• Revenu Canada (RC)
• Santé Canada (SC)
• Secrétariat du Conseil du Trésor du Canada (SCT)
• Sénat du Canada
• Solliciteur général Canada (SGC)
• Transports Canada (TC)

Adresse :
1867 Alta Vista Drive
Ottawa, ON  K1G 5W8
Canada

Numéro de téléphone : 613-731-9331  Poste 2802
Numéro de fax : 613-731-1755  

Représentant du client

William G. Tholl, Secretary General and CEO

Renseignements sur la société mère

Canadian Medical Association n'est pas une filiale d'une société mère.